Related Articles
Dihydroartemisinin increases temozolomide efficacy in glioma cells by inducing autophagy
Dihydroartemisinin triggers c‑Myc proteolysis and inhibits protein kinase B/glycogen synthase kinase 3β pathway in T‑cell lymphoma cells
Dihydroartemisinin inhibits endothelial cell proliferation through the suppression of the ERK signaling pathway
Upregulation of the MCL‑1S protein variant following dihydroartemisinin treatment induces apoptosis in cholangiocarcinoma cells
Dihydroartemisinin and gefitinib synergistically inhibit NSCLC cell growth and promote apoptosis via the Akt/mTOR/STAT3 pathway